An accomplished physician and investment professional, Dr. Mitchell Blutt has spent more than a decade as the head of Consonance Capital, an investment firm in New York City that was one of the first of its kind to specialize in healthcare-related equity opportunities. In addition to this role, Dr. Mitchell Blutt serves on the boards of a number of nonprofit and for-profit organizations, and he formerly served on the board of trustees of Penn Medicine at the University of Pennsylvania.
A prominent Penn Medicine researcher will receive a $4 million dollar grant to help study new methods of diagnosing and treating traumatic brain injuries. Douglas H. Smith, MD, the Robert A. Groff Professor of Neurosurgery at the Perelman School of Medicine, will use the funding from the Pennsylvania Department of Health to look for similarities among patients who suffer these types of injuries in the hope of developing new methods of brain injury prevention, identification, and treatment. Traumatic brain injuries affect some 2.5 million Americans each year, and Dr. Smith says that the current methods of diagnosing and treating them are still not up to par with other areas of modern medicine. He hopes this study will make an important contribution toward closing that gap.